Apogee Therapeutics Inc. (APGE)
(Delayed Data from NSDQ)
$39.88 USD
+0.27 (0.68%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $39.86 -0.02 (-0.05%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Fundamental Charts
About Return on Equity (TTM)
Apogee Therapeutics Inc.'s return on equity, or ROE, is -34.65% compared to the ROE of the Medical - Biomedical and Genetics industry of -65.07%. While this shows that APGE has struggled to make solid use of its equity, this metric will vary significantly from industry to industry.
Return on Equity (or ROE) is calculated as income divided by average shareholder equity (past 12 months, including reinvested earnings). The income number is listed on a company's Income Statement. Shareholder Equity (which is the difference between Total Assets and Total Liabilities) can be found on the Balance Sheet.
APGE 39.88 +0.27(0.68%)
Will APGE be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for APGE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APGE
Wall Street Analysts See a 152.41% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High?
Wall Street Analysts See a 129.09% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High?
APGE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think Apogee Therapeutics Inc. (APGE) Could Surge 132.72%: Read This Before Placing a Bet
Wall Street Analysts Believe Apogee Therapeutics Inc. (APGE) Could Rally 134%: Here's is How to Trade
Other News for APGE
Upper Bollinger Band Walk appears for APGE after 0.68% move
Slingshot Bullish appears for APGE after 0.58% move
Canaccord Genuity Sticks to Their Buy Rating for Apogee Therapeutics (APGE)
APGE forms Shooting Star Candlestick on October 1
Is APGE poised for gains? 200 Day Moving Average Support shows up after sliding 0.25%